Bluebird Bio Inc. buy Barclays PLC
Start price
15.08.24
/
50%
€0.70
Target price
15.08.25
€3.64
Performance (%)
-47.73%
End price
16.08.25
-
Summary
This prediction is currently being closed. Massive losses of -47.73% have been the result for the BUY prediction by Barclays_PLC. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | 0.444% | 3.030% | 12.677% |
| iShares Nasdaq 100 | 3.819% | 4.073% | 33.152% |
| iShares Nikkei 225® | 1.148% | 6.904% | 45.488% |
| iShares S&P 500 | 2.371% | 2.677% | 25.689% |
Comments by Barclays_PLC for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Barclays PLC from $8.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten